Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group (Q44547450)
Jump to navigation
Jump to search
scientific article published in August 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group |
scientific article published in August 2003 |
Statements
1 reference
Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group (English)
1 reference
M Krzakowski
1 reference
Lee S Rosen
1 reference
David Gordon
1 reference
Simon Tchekmedyian
1 reference
Ronald Yanagihara
1 reference
Vera Hirsh
1 reference
M Pawlicki
1 reference
Paul de Souza
1 reference
Ming Zheng
1 reference
Gladys Urbanowitz
1 reference
Dirk Reitsma
1 reference
John J Seaman
1 reference
1 August 2003
1 reference
1 reference
21
1 reference
16
1 reference
3150-3157
1 reference
Identifiers
1 reference
1 reference